Variant report
Variant | nsv981026 |
---|---|
Chromosome Location | chr5:113539925-113544652 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs577955635 | chr5:113540244-113540245 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs147445736 | chr5:113540350-113540351 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs372911043 | chr5:113540366-113540367 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs560386165 | chr5:113540394-113540395 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs189638899 | chr5:113540410-113540411 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs56929721 | chr5:113540427-113540428 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs139558639 | chr5:113540448-113540449 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs542969049 | chr5:113540475-113540476 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs561267374 | chr5:113540484-113540485 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs139148998 | chr5:113540507-113540508 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs569800085 | chr5:113540542-113540543 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs536872367 | chr5:113540578-113540579 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs375629811 | chr5:113540584-113540585 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs192682268 | chr5:113540594-113540595 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs144044374 | chr5:113540595-113540596 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs148654397 | chr5:113540604-113540605 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs370154513 | chr5:113540607-113540608 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs532315422 | chr5:113540631-113540632 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs571781670 | chr5:113540645-113540646 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs6868140 | chr5:113540661-113540662 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
21 | rs565937756 | chr5:113540680-113540681 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs200084534 | chr5:113540779-113540780 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs76527694 | chr5:113540788-113540789 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs374159878 | chr5:113540789-113540790 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs367860984 | chr5:113540790-113540791 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs535907905 | chr5:113540830-113540831 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs554548471 | chr5:113540870-113540871 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs539973470 | chr5:113540877-113540878 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs201295587 | chr5:113540878-113540879 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs569681459 | chr5:113540896-113540897 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs184026341 | chr5:113540901-113540902 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs572378435 | chr5:113540943-113540944 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs34090741 | chr5:113541009-113541010 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs78316188 | chr5:113541017-113541018 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs188755299 | chr5:113541027-113541028 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs545150780 | chr5:113541038-113541039 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs554055168 | chr5:113541088-113541089 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs572690526 | chr5:113541090-113541091 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs181609922 | chr5:113541098-113541099 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs6872938 | chr5:113541100-113541101 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs531573104 | chr5:113541114-113541115 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs543954871 | chr5:113541156-113541157 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs565330264 | chr5:113541209-113541210 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs539435809 | chr5:113541251-113541252 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs186133192 | chr5:113541273-113541274 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs565880296 | chr5:113541287-113541288 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs79639491 | chr5:113541305-113541306 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs371227365 | chr5:113541343-113541344 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs547912704 | chr5:113541371-113541372 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs139743323 | chr5:113541374-113541375 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Colorectal cancer | 16272173 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Neurocytoma | 17123091 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 19377443 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Prostate cancer | 16461572 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Autism | 22495309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:113540200-113541600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
2 | chr5:113540600-113541000 | Enhancers | Cortex derived primary cultured neurospheres | brain |
3 | chr5:113542000-113543600 | Enhancers | Fetal Heart | heart |
4 | chr5:113543600-113544600 | Flanking Active TSS | Fetal Heart | heart |
5 | chr5:113544600-113546800 | Enhancers | Fetal Heart | heart |